黑牡丹(600510.SH)向198名激勵對象授予3141.285萬股限制性股票
格隆匯2月25日丨黑牡丹(600510.SH)公佈,公司於2021年2月25日召開了八屆二十五次董事會會議及八屆十五次監事會會議,審議通過了《關於向公司2020年限制性股票激勵計劃激勵對象授予限制性股票的議案》。公司2020年限制性股票激勵計劃授予的條件已經滿足,根據公司2021年第一次臨時股東大會的授權,現確定2021年2月25日為授予日,以人民幣4.30元/股的授予價格向198名激勵對象授予3141.285萬股限制性股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.